An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment

A. Avan; M. Maftouh; E. Giovannetti

doi:https://doi.org/10.1002/cncr.28116

An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment

A. Avan, M. Maftouh, E. Giovannetti

Medical oncology laboratory (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2662-2663
Journal	Cancer
Volume	119
Issue number	14
DOIs	https://doi.org/10.1002/cncr.28116
Publication status	Published - 2013

Access to Document

https://doi.org/10.1002/cncr.28116

Cite this

Avan, A., Maftouh, M., & Giovannetti, E. (2013). An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment. Cancer, 119(14), 2662-2663. https://doi.org/10.1002/cncr.28116

Avan, A. ; Maftouh, M. ; Giovannetti, E. / An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment. In: Cancer. 2013 ; Vol. 119, No. 14. pp. 2662-2663.

@article{84f8ee9d863b4a6a95a5221712b4c136,

title = "An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment",

author = "A. Avan and M. Maftouh and E. Giovannetti",

year = "2013",

doi = "https://doi.org/10.1002/cncr.28116",

language = "Undefined/Unknown",

volume = "119",

pages = "2662--2663",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "14",

}

Avan, A, Maftouh, M & Giovannetti, E 2013, 'An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment', Cancer, vol. 119, no. 14, pp. 2662-2663. https://doi.org/10.1002/cncr.28116

An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment. / Avan, A.; Maftouh, M.; Giovannetti, E.
In: Cancer, Vol. 119, No. 14, 2013, p. 2662-2663.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment

AU - Avan, A.

AU - Maftouh, M.

AU - Giovannetti, E.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1002/cncr.28116

DO - https://doi.org/10.1002/cncr.28116

M3 - Article

C2 - 23606137

SN - 0008-543X

VL - 119

SP - 2662

EP - 2663

JO - Cancer

JF - Cancer

IS - 14

ER -

Avan A, Maftouh M, Giovannetti E. An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: Implications for adjuvant treatment. Cancer. 2013;119(14):2662-2663. doi: https://doi.org/10.1002/cncr.28116